Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

CARL. live at „Herzmedizin 2022 DIGITAL”

Resuscitec GmbH successfully participated in the digital 51st Annual Meeting of the German Society for Thoracic, Cardiac and Vascular Surgery (DGTHG) and the 54th Annual Meeting of the German Society for Pediatric Cardiology and Congenital Heart Defects e.V. (DGPK) from February 18 to 22, 2022. Registered trade show visitors had the opportunity to learn about CARL at the virtual booth using informational brochures and graphics, and to interact with CARL sales and support staff via chat or video.

Attendees were able to take advantage of a wide range of seminar and corporate workshops at the annual meeting to learn about the latest findings and research topics in thoracic, cardiovascular, and pediatric cardiology and congenital heart disease.

Press contact

Resuscitec GmbH
Engesserstraße 4a
D-79108 Freiburg
press@resuscitec.de

We always use the masculine form in our texts when referring to persons so as not to impair the flow of reading. However, the masculine gender explicitly represents all genders on our website.

Disclaimer

You are receiving the CARL. News mailing based on your relationship with our company. We process your data on the basis of our legitimate interest for the purpose of addressing you personally and sending you our CARL. News mailing. Responsible for the data processing is Resuscitec GmbH. For further information on data protection, please refer to our privacy policy. You can informally object to the processing of your personal data for the dispatch of the CARL. News mailing at any time. Please use the unsubscribe link below to do so.

Note of use

For copyright reasons, the articles may not be passed on to third parties either in print or digital. They are for personal use only. Building up a database with digitizied articles is not allowed.